Total Visits

Views
CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: Results of the HE22A99 trial of the hellenic cooperative oncology group168

Total Visits Per Month

March 2024April 2024May 2024June 2024July 2024August 2024September 2024
CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: Results of the HE22A99 trial of the hellenic cooperative oncology group30410642

Top country views

Views
United States73
Poland52
China17
France4
Sweden4
Australia3
Canada2
Germany2
Ireland2
Argentina1

Top cities views

Views
Warsaw52
Louisville9
Boardman8
Des Moines7
San Ramon7
Falls Church6
Ann Arbor5
San Diego5
Ashburn4
Beijing4